INTRAVENOUS DOSE-LETHALITY STUDY OF AMERICAN PIT VIPER VENOMS IN MICE USING STANDARDIZED METHODS

被引:11
作者
CONSROE, P
GERRISH, K
EGEN, N
RUSSELL, FE
机构
[1] Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona
来源
JOURNAL OF WILDERNESS MEDICINE | 1992年 / 3卷 / 02期
关键词
AMERICAN PIT VIPERS; VENOMS; LD50; MICE; SNAKES; ANTIVENIN;
D O I
10.1580/0953-9859-3.2.162
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An intravenous dose-lethality study of 14 clinically important North and South American pit viper venoms was carried out in mice using standardized, rigorous protocols developed to meet international (WHO) guidelines and US government (FDA) regulations for the development of new treatment products. The study was undertaken in order to establish baseline LD50 values for the ongoing testing of a new crotalid antivenin F(AB) prepared from sheep immunoglobulin (IgG). The venoms (lyophilized and pooled from juvenile and adult snakes of both sexes) were taken from 10 rattlesnake (nine Crotalus and one Sistrurus) species, two Agkistrodon species, and two Bothrops species. The dose-response data were subjected to probit analysis. Median lethal dose (LD50) values and their 95% confidence limits (CL) were calculated and statistical comparisons between the median potencies were made. The intravenous LD50s (and 95% CL) ranged from a low of 0.13 (0.10-0.15) mg kg-1 for Crotalus durissus terrificus, to a high of 6.32 (5.76-6.94) mg kg-1 for Crotalus horridus horridus. Significant positive rank-order correlations were also found for comparisons between the present LD50s and published LD50s for intravenous, intraperitoneal, and subcutaneous administration.
引用
收藏
页码:162 / 167
页数:6
相关论文
共 20 条
[1]  
Minton S.A., Some properties of North American pit viper venoms and their correlation with phytogeny, Venoms, pp. 145-151, (1956)
[2]  
Russell F.E., Puffer H.W., Pharmacology of snake venoms, Clin Toxicol, 3, pp. 433-434, (1970)
[3]  
Glenn J.I., Straight R.C., The rattlesnakes and their venoms and lethal toxicity, Rattlesnake Venoms: Their Actions and Treatments, pp. 3-119, (1982)
[4]  
Bolanos R., Toxicity of Costa Rican snake venoms for the white mouse, Am J Trop Med Hyg, 21, pp. 360-363, (1972)
[5]  
Russell F.E., Snake Venom Poisoning. Great Neck, (1983)
[6]  
Requirements for snake antivenins (Requirements for Biological Substances, No. 21), WHO Tech Rep Sec, 463, pp. 27-44, (1971)
[7]  
Theakston R.D.G., Reid H.A., Development of simple standard assay procedures for the characterization of snake venoms, Bull WHO, 61, pp. 949-955, (1983)
[8]  
Aird S.D., Kaiser L.I., Toxicity assays, Toxicon, 23, pp. 11-13, (1985)
[9]  
Russell F.E., Snake venom immunology: historical and practical considerations, J Toxicol-Toxin Rev, 7, pp. 1-82, (1988)
[10]  
Gutierrez J.M., Rojas G., Lomonte B., Gene J.A., Chaves F., Alvarado J., Rojas E., Standardization of assays for testing the neutralizing ability of antivenoms, Toxicon, 28, pp. 1127-1129, (1990)